Veronica has broad experience in the life science and healthcare sectors. She has built early-stage companies and managed larger international organizations, with functional responsibilities including general management, sales & marketing, business development and technical operations. Currently Veronica provides business strategy and operations expertise to product and service-based organizations developing new healthcare products. She serves on the board of directors of AMRI (Albany Molecular Research Inc.), a NASDAQ traded company providing drug discovery services and contract manufacturing and is a managing director of Golden Seeds, a national angel investor group dedicated to investing in early stage companies founded and/or led by women. Veronica’s previous experience includes President and CEO of a venture capital-backed medical device company and various executive positions at PAREXEL International, a leading contract pharmaceutical outsourcing organization providing worldwide clinical research services. Earlier, she held positions of increasing business leadership at Biogen and managed a R&D department for Baxter International. Veronica has a BA/MA in biochemistry from Cambridge University, UK and a Ph.D. in biochemistry/cell biology from Oxford University, UK. She conducted post-doctoral research at the Dana Farber Cancer Institute, Harvard Medical School.